Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mathilda L. Bongers

Cost Effectiveness of Treatment With New Agents in Advanced Non-Small-Cell Lung Cancer

PharmacoEconomics

Occupational Health

English

Related publications

Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)

Value in Health

Occupational Health

English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy

English

Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy

English

Pcn152 - Cost Effectiveness of Alectinib in the First Line Treatment of Advanced Alk-Positive Non-Small Cell Lung Cancer in Turkey

Value in Health

Occupational Health

English

Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer

Cancer Research

English

Cost-Effectiveness of Hypothetical New Cancer Drugs in Patients With Advanced Small-Cell Lung Cancer: Results of a Markov Chain Model

Therapeutics and Clinical Risk Management

Chemical Health

Safety Research

English

Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

English

Pcn145 - Cost-Effectiveness of Nintedanib for the Treatment of Non-Small Lung Cancer in Portugal

Value in Health

Occupational Health

English

Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer

Cancer Research

English